Overview
Status
Suspended
Registry date
2020-12-28
Share capital
5 300,00 PLN
Registered address
ul. Szafarnia 11/F8, 80-755 Gdańsk, Poland
Electronic delivery address
AE:PL-43311-87535-WRSBE-22
Financials
Revenue history (in k)
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 81 days late).
- 202530/06/2026
- 202410/07/2025
- 202302/07/2024
- 202207/07/2023
- 202104/10/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 8.55kMedianUSD 55.35kAverageUSD 2.71m
Net profit
This companyUSD 7.93kMedianUSD -1.27kAverageUSD -92.09k
Operating costs
This companyUSD 437.22MedianUSD 66.19kAverageUSD 2.67m
Assets
This companyUSD 238.69kMedianUSD 133.95kAverageUSD 3.03m
Industry
Authorized Representatives
Adam Kruszewski – Management Board Member
Manner of representation
Each member of the management board independently.
Supervisory board
Artur Płonowski – Supervisory Board Member
Randy John Berholtz – Supervisory Board Member
Robert Leo Buchanan – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ambulero, Inc. | 52 | $1,404.65 | 98.1132% |
Others | 1 | $27.01 | 1.8868% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-05-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Innervisionsp. z o.o. | $4.54 | innervision.pl | ||
| UrtesteS.A. | – | urteste.com | ||
| Astrofoodssp. z o.o. | – | astrofarms.space |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-03 | Business suspended | |
| 2026-08-02 | Business resumed | |
| 2024-08-01 | Business suspended | |
| 2021-06-14 | Address change (Ul. Poznańska 37, 00-689, Warszawa → Ul. Szafarnia 11/F8, 80-755, Gdańsk) | |
| 2021-06-14 | Share capital change (5,200.00 PLN → 5,300.00 PLN) |
FAQ
The main business activity of Ambulero focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on December 28, 2020.
The headquarters is located at: ul. Szafarnia 11, 80-755 Gdańsk.
The management board consists of: Adam Kruszewski (Member of the Management Board).
The share capital of the company is PLN 5,300 (approx. $1,432).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $8,551, representing a decrease of 24.7% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $7,930, meaning the company decreased its profit by 16.8%.
The largest operating cost category falls under external services. This category amounted to $437 in 2025, representing 100% of all operating expenses.
Last updated: 2026-08-06
